Gary T. Ferguson

Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

Peter Calverley, Julie A. Anderson, Bartolomé R. Celli et al. · New England Journal of Medicine · 2007 · 3.3K citations · Full text

Medicine, Pharmacology, Pulmonology +1

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair et al. · The Lancet · 2016 · 1.4K citations

Pharmacy, Immunology, Pharmacology +17

Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study

Bartolomé R. Celli, Nicola E. Thomas, Julie A. Anderson et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 746 citations

Medicine, Pharmacology, Pharmacotherapy +17

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

Klaus F. Rabe, Fernando J. Martinez, Gary T. Ferguson et al. · New England Journal of Medicine · 2020 · 691 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Adherence to inhaled therapy, mortality and hospital admission in COPD

Jørgen Vestbo, Julie A. Anderson, Peter M.A. Calverley et al. · Thorax · 2009 · 524 citations · Full text

Medicine, Oncology, Pharmacology +14